News
Akadeum Life Sciences Strengthens Leadership With CFO Appointment, Jim Militello
September 2023 Share
Ann Arbor, MI, September 12, 2023 – Akadeum Life Sciences, the global leader in buoyancy-based cell separation, have today announced Jim Militello as their new Chief Financial Officer (CFO), effective September 12, 2023. Jim will play a key role in overseeing the fundraising, financial analysis and strategic planning of Akadeum as it continues its rapid growth in a market set to surpass $11.6bn by 2030. With a career spanning over …
Akadeum Life Sciences Release Their Revolutionary Human T cell Activation and Expansion Kit
September 2023 Share
The gentle microbubble floatation process not only produces healthier cells, but is also a quicker, more efficient, and cost effective solution compared to outdated legacy methods. ANN ARBOR, Mich., Sept. 7, 2023 – Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their ‘Human T Cell Activation & Expansion Kit’ with Buoyancy Activated Cell Sorting (BACS) microbubbles. The first-of-its-kind kit is designed …
Akadeum CEO Brandon McNaughton Part of Michigan Founders Fund Milestone
August 2023 Share
Brandon McNaughton, CEO and co-founder of Akadeum Life Sciences, was recently highlighted with other influential Michigan-based thought leaders in a Purpose Job’s recent article celebrating Michigan Founders Fund’s 100-member milestone. The Michigan Founders Fund (MFF) recently celebrated reaching over 100 members in its statewide venture network supporting high-growth entrepreneurs. MFF members pledge 1% of equity to a fund for grantmaking focused on underrepresented founders, local talent development, and racial equity. …
Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines at ASGCT 26th Annual Meeting
May 2023 Share
The company that pioneered microbubbles for cell isolation is launching a first-of-its-kind product that uses microbubbles to activate T Cells and releasing the first GMP-grade microbubble product for T cell isolation. Ann Arbor, MI, May 16, 2023 – Akadeum Life Sciences, a global leader in buoyancy-based cell separation and activation technology, is announcing the launch of a new series of products for cell therapy research and development—enabling direct leukopak human …
Akadeum Life Sciences Named in Top 10 Most Innovative Biotech Companies of 2023 by Fast Company
March 2023 Share
The global leader in buoyancy-based cell separation technology recognized for innovation solving workflow challenges in cell and gene therapy research and development ANN ARBOR, Mich., March 02, 2023 — Akadeum Life Sciences Inc., a global leader in buoyancy-based cell separation technology, announces today it has been named in Fast Company’s 10 Most Innovative Biotech Companies of 2023 as part of the prestigious annual list of the World’s Most Innovative Companies. Akadeum’s patented cell …
Akadeum Advances Platform Toward Cell Therapy Applications, New Data Revealed at Biotech Showcase and Development-Stage Automated Instrument Previewing at Advanced Therapies Week
January 2023 Share
The company that pioneered microbubbles for cell isolation and activation shares new data and capabilities, demonstrating impactful advancements for cell and gene therapy applications ANN ARBOR, Mich., Jan. 17, 2023 — Akadeum Life Sciences Inc., a global leader in buoyancy-based cell separation technology, announced today that it will preview its automated platform at Phacilitate’s Advanced Therapies Week, January 17-20th in Miami, Florida. At Advanced Therapies Week, Akadeum will also share early adopter …
Akadeum Life Sciences Launches First of its Kind Product Benefitting Cell and Gene Therapy Research Following Successful Data from Early Access Program
December 2022 Share
Positive Results Spurs Launch of Akadeum’s Leukopak Isolation Kit citing speed, scalability, and cell recovery among prized attributes from biospecimen providers and cell and gene therapy developers ANN ARBOR, Mich., Dec. 21, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces their Microbubble Leukopak Human T Cell Isolation research-use-only kit that resulted from successful external user data with early adopters. Akadeum’s T cell isolation …
Immune Control and Evasion During Acute and Chronic HBV Infection
November 2022 Share
Investigating the role of T cell exhaustion and T cell memory in hepatitis B virus infections Dr. Hannah Drescher, a Postdoctoral Research Fellow in Professor Georg Lauer’s lab at Mass Gen Hospital and Harvard Medical School, used Akadeum’s Human CD4+ T Cell Isolation Kit with BACS™ Microbubbles to isolate cells to study the role of T cells during acute and chronic HBV infection. Specifically, Hannah is interested in studying the …
Cloning Mouse B Cells for Antibody Production Using Akadeum’s Novel High-Throughput Mouse B Cell Isolation Microbubbles
November 2022 Share
In a Head-to-Head Comparison Akadeum’s Mouse B Cell Isolation Microbubbles Generated 32% More Positive Antigen-Specific Antibodies Compared to Magnetic-Based Procedures Abbratech compared Akadeum’s novel Mouse B Cell Isolation Kit with buoyancy-activated cell sorting (BACSTM) microbubbles to a negative selection magnetics-based kit for isolation of B cells from fresh splenocytes to determine which process would be incorporated into their mouse B cell cloning workflow. After enrichment, samples were cultured under various …
Putting People First for Meaningful Innovation
November 2022 Share
This article by Akadeum’s CEO Dr. Brandon H. McNaughton was originally published in CEOWorld Magazine. The secret to a truly great organization is the values and beliefs that exist at its core. Since the founding of Akadeum Life Sciences in 2014, the standards we uphold are to diligently help people solve problems in their lab work around separating cells, nucleic acids, or proteins from biological samples. This separation step is …